X-15517955-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_203281.3(BMX):c.472G>A(p.Glu158Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000108 in 1,206,033 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_203281.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BMX | NM_203281.3 | c.472G>A | p.Glu158Lys | missense_variant | 6/19 | ENST00000348343.11 | |
BMX | NM_001721.7 | c.472G>A | p.Glu158Lys | missense_variant | 6/19 | ||
BMX | NM_001320866.2 | c.472G>A | p.Glu158Lys | missense_variant | 6/19 | ||
BMX | XM_017029752.3 | c.472G>A | p.Glu158Lys | missense_variant | 6/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BMX | ENST00000348343.11 | c.472G>A | p.Glu158Lys | missense_variant | 6/19 | 1 | NM_203281.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000267 AC: 3AN: 112366Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34540
GnomAD4 exome AF: 0.00000914 AC: 10AN: 1093667Hom.: 0 Cov.: 27 AF XY: 0.0000167 AC XY: 6AN XY: 359743
GnomAD4 genome AF: 0.0000267 AC: 3AN: 112366Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34540
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 22, 2023 | The c.472G>A (p.E158K) alteration is located in exon 6 (coding exon 5) of the BMX gene. This alteration results from a G to A substitution at nucleotide position 472, causing the glutamic acid (E) at amino acid position 158 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at